Canadian Technology Stocks
BufferA cursory glance at a three-year chart of Belleville’s Bioniche Life Sciences (TSX:BNC) illustrates the promise and subsequent disappointment of the company’s plans to expand beyond its core business. A closer look reveals a minor resurgence is underway, as the company has focused on the bottom line during the transition. For years, Bioniche was better [...]
BufferThe voting for 2010 Canadian Tech Stock of the Year contained some obvious choices. SXC Health, for instance, added a billion dollars in market value and posted a 40% top line gain. Westport Innovation’s stock continued a dramatic run that began in 2009. In 2010 it was also revealed that legendary investor George Soros became [...]
BufferAnother year, and another year of mining stock successes on the Toronto Stock Exchange. It seems like decades since a technology stock really made a difference to the index, and 2010 was not the year to break that pattern. In fact, only one technology related issue cracked the top thirty five performing stocks on the [...]
When we decided to hold the first ever Cantech Letter Awards we were immediately faced with some tough choices. How many categories should there be? Which companies should be eligible? Should we simply take the ten best performing stocks and let our readers vote on them? What about revenue growth, is that more important than share price? Perhaps a combination of the two? Should a percentage gain in either be weighted more heavily to larger stocks? In the end we decided on two categories: Canadian Technology Stock of the Year and Canadian Technology Executive of the Year. We also invited a panel of judges to help us to not only choose the winners, but also the candidates…
It’s been nearly a century since Canada’s greatest achievement in biotech took place; the discovery of insulin by Frederick Banting and his assistant Charles Best, in 1922. While nothing since has matched that miraculous feat, which has saved countless millions of lives, it’s not like Canada has been sitting still in the meantime. Canadian researchers have contributed to The Human Genome project, cracked the genetic code of the mosquito that carries the deadliest strain of malaria, and deciphered human chromosome 7, which holds the gene for cystic fibrosis. Our December issue is about Canadian Life Sciences stocks carrying the torch of innovation.
BufferIt’s been nearly a century since Canada’s greatest achievement in biotech took place; the discovery of insulin by Frederick Banting and his assistant Charles Best, in 1922. While nothing since has matched that miraculous feat, which has saved countless millions of lives, it’s not like Canada has been sitting still in the meantime. Canadian researchers [...]
BufferFor years, Belleville, Ontario’s Bioniche Life Sciences (TSX:BNC) was better known to your veterinarian than your doctor. Bioniche, which formed in 1979 to develop veterinary bio pharmaceutical products, received worldwide attention two years ago when it received a Canadian license for Econiche, the world’s first cattle vaccine against E. coli. Sales of Bioniche veterinary products [...]
Buffer 2010: The Top 20 Canadian Techs (So far) This Year 2009 was a year of recovery for the worldwide markets, and Canadian tech stocks were no exception. Led by DragonWave (TSX:DWI) which began the year as a TSX Venture stock and ended with a full big board listing and a share price in excess [...]
